Literature DB >> 15096288

A community-based breast cancer screening program for medically underserved women: its effect on disease stage at diagnosis and on hazard of death.

Clyde B McCoy1, Margaret Pereyra, Lisa R Metsch, Fernando Collado-Mesa, Sarah E Messiah, Sandy Sears.   

Abstract

OBJECTIVE: Earlier studies by this research team found that medically underserved minority women in the Miami-Dade County area of the state of Florida, United States, were in need of breast cancer screening and that there were problems with availability, accessibility, and acceptability of services. In response, a community-based comprehensive breast cancer screening program called the Early Detection Program (EDP) was developed. The specific purpose of this study was to assess the effect that EDP participation had on stage at diagnosis and on hazard of death.
METHODS: Existing data from the Florida Cancer Data System (FCDS), a statewide cancer registry, were linked with data from the EDP. In December 1998 we assembled a multiethnic (African-American, black Hispanic, white Hispanic, and white non-Hispanic) retrospective cohort with the following inclusion criteria: all women aged 40 and older with breast cancer diagnosed and staged at University of Miami/Jackson Memorial Medical Center (which is located in the city of Miami, Florida) from January 1987 through December 1997. EDP participants were medically underserved, that is, they resided in lower socioeconomic areas and/or had limited or no health insurance to cover medical costs. Subjects identified as EDP participants were compared to nonparticipants with respect to disease stage at diagnosis and hazard of death. Logistic regression and Cox regression models were used for analysis.
RESULTS: EDP participants were 2.4 times as likely (95% confidence interval = 1.71 to 3.43) to present with a diagnosis of localized cancer as were nonparticipants, even after controlling for race and age at diagnosis. EDP participation was independently associated with both earlier diagnosis and reduced hazard of death.
CONCLUSIONS: Participation in the EDP increases the likelihood of early detection of breast cancer and reduces the hazard of death for medically underserved women in the Miami-Dade County area of Florida. Interestingly, white Hispanics showed a better survival than did both African-Americans and white non-Hispanics. Our research also demonstrates the value of utilizing existing cancer registry data to evaluate a community-based program such as the EDP.

Entities:  

Mesh:

Year:  2004        PMID: 15096288     DOI: 10.1590/s1020-49892004000300004

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  5 in total

1.  Breast cancer characteristics and outcomes among Hispanic Black and Hispanic White women.

Authors:  Matthew P Banegas; Christopher I Li
Journal:  Breast Cancer Res Treat       Date:  2012-07-08       Impact factor: 4.872

2.  Cancer screening participation: comparative willingness of San Juan Puerto Ricans versus New York City Puerto Ricans.

Authors:  Cristina Claudio; Ralph V Katz; B Lee Green; Nancy R Kressin; Min Qi Wang; Stefanie L Russell
Journal:  J Natl Med Assoc       Date:  2007-05       Impact factor: 1.798

3.  Differences in breast cancer outcomes amongst Black US-born and Caribbean-born immigrants.

Authors:  Priscila Barreto-Coelho; Danielle Cerbon; Matthew Schlumbrecht; Carlos M Parra; Judith Hurley; Sophia H L George
Journal:  Breast Cancer Res Treat       Date:  2019-08-14       Impact factor: 4.872

4.  Willingness to participate in cancer screenings: blacks vs whites vs Puerto Rican Hispanics.

Authors:  Ralph V Katz; Cristina Claudio; Nancy R Kressin; B Lee Green; Min Qi Wang; Stefanie Luise Russell
Journal:  Cancer Control       Date:  2008-10       Impact factor: 3.302

5.  Level and Factors Associated with Participation in Population-Based Cancer Screening in Safranbolu District of Karabuk, Turkey.

Authors:  Raziye Özdemir; Fatma TÜrkmen Çevik; Duygu Kes; Merve Karacali; Simge ÖzgÜner
Journal:  Iran J Public Health       Date:  2020-04       Impact factor: 1.429

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.